- Home
- NPCE vs NRC Comparison
NPCE vs NRC Comparison
Compare NPCE & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- NRC
- Stock Information
- Founded
- NPCE 1997
- NRC 1981
- Country
- NPCE United States
- NRC United States
- Employees
- NPCE N/A
- NRC N/A
- Industry
- NPCE Medical Specialities
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NPCE Health Care
- NRC Health Care
- Exchange
- NPCE Nasdaq
- NRC Nasdaq
- Market Cap
- NPCE 292.9M
- NRC 354.5M
- IPO Year
- NPCE 2021
- NRC N/A
- Fundamental
- Price
- NPCE $9.15
- NRC $14.65
- Analyst Decision
- NPCE Strong Buy
- NRC
- Analyst Count
- NPCE 6
- NRC 0
- Target Price
- NPCE $16.67
- NRC N/A
- AVG Volume (30 Days)
- NPCE 205.3K
- NRC 101.8K
- Earning Date
- NPCE 08-12-2025
- NRC 10-24-2025
- Dividend Yield
- NPCE N/A
- NRC 3.27%
- EPS Growth
- NPCE N/A
- NRC N/A
- EPS
- NPCE N/A
- NRC 0.77
- Revenue
- NPCE $88,570,000.00
- NRC $140,314,000.00
- Revenue This Year
- NPCE $22.13
- NRC N/A
- Revenue Next Year
- NPCE $6.07
- NRC N/A
- P/E Ratio
- NPCE N/A
- NRC $19.08
- Revenue Growth
- NPCE 23.32
- NRC N/A
- 52 Week Low
- NPCE $5.45
- NRC $9.76
- 52 Week High
- NPCE $18.98
- NRC $22.99
- Technical
- Relative Strength Index (RSI)
- NPCE 51.74
- NRC 47.80
- Support Level
- NPCE $8.61
- NRC $14.45
- Resistance Level
- NPCE $8.99
- NRC $15.60
- Average True Range (ATR)
- NPCE 0.53
- NRC 0.64
- MACD
- NPCE 0.11
- NRC -0.03
- Stochastic Oscillator
- NPCE 75.00
- NRC 17.05
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.